|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product sales, net | |||||
| Total revenue | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Restructuring charges | |||||
| Cost of goods sold | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Gain on sale of business | |||||
| Foreign exchange gain (loss) | |||||
| Other income | |||||
| Interest income | |||||
| Interest expense | |||||
| Total other income (expense), net | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive loss: | |||||
| Unrealized (loss) income on available-for-sale debt securities | |||||
| Unrealized gain (loss) on investments, net of tax | |||||
| Comprehensive loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding, basic (in shares) | |||||
| Weighted average number of common shares outstanding, diluted (in shares) | |||||
Loading...